Current State and Challenges of the Pharmaceutical Industry, Speakers from Baxalta, Prolacta, Avid Bio

Building an Advanced Global Reliability Program

Shawn Ansari, Sr. Director, Head,Engineering Operations, US/Singapore, Baxalta

 

The Power of Human Touch
Prolacta introduction, history of leadership in Human Milk Science, product overview, clinical evidence, production process.

Joe Fournell, VP, Operations, Prolacta Bioscience®

Biologics Manufacturing: Single Use Systems

Steve King, CEO Peregrine Pharmaceuticals Inc. and Avid Bioservices

Program Managers:
Paul Crissman, Biotechnical Solutions
Dona Tseng, Sr. Principal Engineer, Baxalta

About the Speakers

Shawn Ansari, Sr. Director, Head of Engineering Operations, US and Singapore, Baxalta

Shawn’s experience spans over 25 years working in pharmaceutical and biotech industries. He has worked in both research and manufacturing facilities (Active Ingredient Pharmaceutical – API Plants and Clinical Trials Manufacturing Plants) with continued increasing responsibilities.

At Baxalta, he is directly responsible for all aspects of engineering operations in four manufacturing facilities in the US and one in Singapore. Engineering operations include plant, process, automation, project, and reliability engineering as well as the facility, maintenance, utilities, and site services departments. He has created a “House of Reliability”

He has previous experience being head of engineering and facilities for Baxter International, Shire Pharmaceuticals, Amgen and Eli Lilly.

He has a BS in Chemistry from Thomas More College, MS in Chemical Engineering from Purdue University, and a MBA from Krannert School of Management at Purdue University.

Joe Fournell, VP, Operations, Prolacta Bioscience®

Joe Fournell has over a decade of experience in the field of operations and supply chain management in the high-tech and bioscience sectors. Throughout his career, he has held leadership roles in operations, manufacturing execution systems, forecasting, supply planning, process engineering, and logistics.

Most recently, he served as director of global logistics for Baxter Bioscience. In this capacity, he managed the transportation, warehousing, and distribution of over $3 billion of product globally. At Baxter Bioscience, he led strategy planning sessions for operations, regulatory, and human resources. In his prior role at Baxter Bioscience, he became the first certified Six Sigma Black Belt in the U.S., working on process improvements in the manufacturing and supply chain arena.

He received a Bachelor of Science in Industrial Engineering at California Polytechnic State University, San Luis Obispo, with an emphasis on process engineering. He also received a Master of Science degree in Industrial Engineering at California Polytechnic State University, San Luis Obispo, with a focus on factory automation, funded from a grant through NASA-AMES and Raytheon.

Steve King, CEO Peregrine Pharmaceuticals Inc. and Avid Bioservices

Steven King has been president and chief executive officer of Peregrine Pharmaceuticals, Inc. since March 2003. He started with Peregrine in 1997 as the director of research and development before being promoted to senior director of research and development and then to vice president of technology and product development.  In 2000, he was responsible for bringing the company’s biologics manufacturing facility into full cGMP compliance and subsequently launching its wholly owned contract manufacturing subsidiary, Avid Bioservices. In 2001, he began serving as president and CEO of Avid Bioservices, Prior to joining Peregrine, King was employed at a company that was developing vascular targeting agents (VTA), which was acquired by Peregrine in 1997.

He previously worked with Dr. Philip Thorpe, inventor of VTA technology, at the University of Texas Southwestern Medical Center at Dallas. King is a co-inventor on over 25 U.S. and foreign patents and patent applications in the VTA area. He holds bachelor’s and master’s degrees in biology from Texas Tech University.

Tagged , , , , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: